Compare GRANULES INDIA with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs CADILA HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA CADILA HEALTHCARE GRANULES INDIA/
CADILA HEALTHCARE
 
P/E (TTM) x 16.3 20.5 79.3% View Chart
P/BV x 3.6 3.7 96.5% View Chart
Dividend Yield % 0.5 0.7 65.0%  

Financials

 GRANULES INDIA   CADILA HEALTHCARE
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
CADILA HEALTHCARE
Mar-21
GRANULES INDIA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs438509 86.0%   
Low Rs138259 53.4%   
Sales per share (Unadj.) Rs130.7147.5 88.6%  
Earnings per share (Unadj.) Rs22.220.9 106.2%  
Cash flow per share (Unadj.) Rs28.328.0 101.2%  
Dividends per share (Unadj.) Rs1.503.50 42.9%  
Avg Dividend yield %0.50.9 57.1%  
Book value per share (Unadj.) Rs86.8126.9 68.4%  
Shares outstanding (eoy) m247.671,023.74 24.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.22.6 84.7%   
Avg P/E ratio x13.018.4 70.6%  
P/CF ratio (eoy) x10.213.7 74.1%  
Price / Book Value ratio x3.33.0 109.6%  
Dividend payout %6.816.8 40.3%   
Avg Mkt Cap Rs m71,337393,092 18.1%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24322,548 14.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,375151,022 21.4%  
Other income Rs m269449 59.9%   
Total revenues Rs m32,644151,471 21.6%   
Gross profit Rs m8,55231,335 27.3%  
Depreciation Rs m1,5157,248 20.9%   
Interest Rs m2631,688 15.6%   
Profit before tax Rs m7,04422,848 30.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5491,472 105.2%   
Profit after tax Rs m5,49521,376 25.7%  
Gross profit margin %26.420.7 127.3%  
Effective tax rate %22.06.4 341.4%   
Net profit margin %17.014.2 119.9%  
BALANCE SHEET DATA
Current assets Rs m19,97087,160 22.9%   
Current liabilities Rs m11,73178,613 14.9%   
Net working cap to sales %25.45.7 449.7%  
Current ratio x1.71.1 153.5%  
Inventory Days Days1633 49.0%  
Debtors Days Days86376 1,141.7%  
Net fixed assets Rs m17,157140,943 12.2%   
Share capital Rs m2481,024 24.2%   
"Free" reserves Rs m21,262128,899 16.5%   
Net worth Rs m21,510129,923 16.6%   
Long term debt Rs m3,4116,095 56.0%   
Total assets Rs m37,127228,103 16.3%  
Interest coverage x27.814.5 191.2%   
Debt to equity ratio x0.20 338.1%  
Sales to assets ratio x0.90.7 131.7%   
Return on assets %15.510.1 153.4%  
Return on equity %25.516.5 155.3%  
Return on capital %29.318.0 162.5%  
Exports to sales %81.90-   
Imports to sales %26.810.5 254.8%   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,69115,911 54.6%   
Fx inflow Rs m26,52863,535 41.8%   
Fx outflow Rs m8,69115,911 54.6%   
Net fx Rs m17,83747,624 37.5%   
CASH FLOW
From Operations Rs m4,32532,930 13.1%  
From Investments Rs m-2,771-7,225 38.4%  
From Financial Activity Rs m-2,993-25,489 11.7%  
Net Cashflow Rs m-1,441-905 159.2%  

Share Holding

Indian Promoters % 41.7 74.9 55.7%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 24.0 15.4 155.2%  
FIIs % 0.0 4.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 25.1 230.7%  
Shareholders   239,520 351,595 68.1%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   ZANDU REALTY  ALCHEMIST LIMITED  PARNAX LAB  AMBALAL SARABHAI  THEMIS MEDICARE  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of CADILA HEALTHCARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Nov 26, 2021 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 5-YR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS